Si-Bone (SIBN) Cash & Equivalents (2017 - 2026)

Si-Bone's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $33.5 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 18.58% year-over-year to $33.5 million in Q1 2026; TTM through Mar 2026 was $33.5 million, a 18.58% decrease from a year earlier, with the FY2025 full-year figure at $42.2 million, up 20.87% from the prior year.
• Cash & Equivalents declined to $33.5 million in Q1 2026 per SIBN's latest filing, from $42.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $93.1 million in Q2 2023 and bottomed at $8.0 million in Q4 2022.
• The 5-year median for Cash & Equivalents is $26.2 million (2024), against an average of $31.5 million.
• Across the five-year window, Cash & Equivalents slumped 86.16% in 2022 and jumped 414.55% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $8.0 million in 2022, then jumped by 191.56% to $23.3 million in 2023, then jumped by 49.79% to $34.9 million in 2024, then rose by 20.87% to $42.2 million in 2025, then retreated by 20.61% to $33.5 million in 2026.
• Per Business Quant, the three latest SIBN Cash & Equivalents figures stand at $33.5 million (Q1 2026), $42.2 million (Q4 2025), and $26.5 million (Q3 2025).